Strapped for cash, Lombard Medical defaults on loan

January 16, 2018 By Brad Perriello Leave a Comment

Strapped for cash, Lombard Medical Technologies (NSDQ:EVAR) said last week that it received a default notice from one of its lenders.

The Didcot, U.K.-based stent graft maker said Oxford Finance sent the default letter Jan. 12, four days after meeting with Lombard to discuss its finances.

To make matters worse, Lombard said it doesn’t have enough cash on hand to make it past the first half of the year.

“[U]nless additional financing becomes available, the company expects to exhaust its current cash resources in the period between Q1 2018 and Q2 2018,” the company said in a regulatory filing.

“The company is communicating with Oxford in an effort to restructure its obligations under the loan and security agreement. There are no assurances that the company will be able to successfully restructure such obligations. Pursuant to the terms of the loan and security agreement, at this time Oxford may pursue all its available remedies with respect to the company’s obligations or collateral securing such obligations, including seeking immediate repayment,” Lombard said in the filing.

In April 2016, Lombard shuffled the deck after bailing out of the U.S. market due to an FDA decision requiring a 50-patient clinical study of its Intelliflex low-profile delivery system for the Aorfix stent graft. Then based in Irvine, Calif., the company eliminated its U.S. sales force and moved most of its commercial operations to the U.K., significantly reducing its cash burn.

See the next generation of leaders at DeviceTalks Minnesota!

On June 4-5, DeviceTalks is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring, bringing you the best and brightest minds in the industry.

KEYNOTE SPEAKERS

Heidi Dohse: Sr. Program Manager, Healthcare, Google, Founder, Tour de Heart Foundation, Acessa Health Inc. Michael J. Pederson: Senior Vice President, Cardiac Arrhythmias and Heart Failure Division, Abbott Hon. Melvin Carter: Mayor, Saint Paul Tim Philips: Compliance Officer, FDA’s Office of Medical Device and Radiological Health Operations Dr. Myriam J. Curet, MD, FACS: Chief Medical Officer, Intuitive Surgical

Take a look at our incredible line up of speakers and join us now.

Use the code "KEYNOTE" to save 15% on the cost of registration.

REGISTER TODAY

May 2018 issue: DeviceTalks Minnesota Show preview, the hottest medtech startups of 2018 and more.
Minnesota continues to attract medtech innovators California, especially Silicon Valley, may have a reputation as an epicenter of digital health. But while researching the health of the Minnesota medtech hub, I came to an important realization: There is actually a lot going on in the North Star State. Here’s just a sample of the recent […]
Fermatex returning to familiar Adam Spence name
Fermatex Vascular Technologies (Wall, N.J.) — formerly WL Gore Jersey Shore and most notably Adam Spence — said today that it is rebranding back to the Adam Spence name. The name change will be effective June 4. Company officials said that going back to the Adam Spence name will help the company benefit from Adam Spence’s […]
How 3D printing is boosting cancer treatment
Radiologists are creating patient-specific, life-sized 3D printed models to show the location of tumors in bones, organs, nerves and blood vessels. The 3D printing method could help doctors plan treatments for different types of cancers and tumors. In the past, 3D printing has been a valuable tool for clinicians to plan surgeries and make implants […]
This tattoo-like sensor measures blood glucose levels non-invasively
Diabetes tracking can be a scary and tedious task, but University of California at San Diego researchers have developed a needless glucose monitor tattoo sensor that measures insulin levels through sweat on the skin. There are approximately 30.3 million people living with diabetes in the U.S., according to the American Diabetes Association. Monitoring blood sugar […]
6 reasons you shouldn’t bet on blockchain disrupting healthcare
Blockchain is the big buzzword these days, bruited as a disruptive force for industries covering the spectrum. But there seems to be little understanding of what exactly “blockchain” means, let alone how it could affect so many different markets so profoundly. Simply put, a blockchain is a decentralized database with tight rules about how data […]
How SABIC helped develop a non-drug migraine treatment
SABIC recently helped eNeura develop a clinically proven, non-drug option for preventing and treating migraine headaches. The sTMS mini from eNeura is a portable delivery system for single-pulse, transcranial magnetic stimulation. It’s prescribed by a physician. FDA cleared the sTMS mini for migraine prevention in 2017. SABIC’s polycarbonate copolymer Lexan was chosen as the housing of […]
8 companies commercializing transcatheter mitral valve replacements
Transcatheter mitral valve replacement is a new frontier in the cardio device field, with big legacy medical device companies including Edwards Lifesciences, Medtronic and Abbott spending hundreds of millions of dollars on companies in the space. Much different from transcatheter aortic valve replacement (TAVR), transcatheter mitral valve replacement (TMVR) has been mostly experimental. TMVR is used […]
4 ways medtech contractors are evolving (and why)
The present and near future for medtech contractors will rely on specific strategies such as tiered partnerships and consolidation, an emphasis on speed, and owning therapeutic and technology spaces. Andrew Potter, Bonifacio Consulting Services, and Christopher Delporte In the first article in this series, we examined some of the important trends during the last 10–15 years […]
Minnesota’s Medical Alley has a big presence at EuroPCR
The Medical Alley Association in Minnesota is touting the major presence that companies and organizations from the state will have at this year’s EuroPCR, which is being held this week in Paris. The event — the European Association of Percutaneous Cardiovascular Interventions’ annual meeting — is May 22–25 at the Palais des Congrès and is expected to […]
Will FDA turn to neuroscience-based human factors research?
There is a new wind blowing in medical technology — one that many believe is overdue: an overhaul of human factors. At the recent Patient Safety Initiative, Charles Murphy, Chief Patient Safety Officer at the Inova Heart and Vascular Institute, called out human factors as one of the key factors he believed needed to be […]
High-volume manufacturing: Essential points to consider before you scale up
High-volume manufacturing typically involves the introduction of automation into the medical device fabrication and assembly process. A number of benefits usually follow: repeatability, heightened quality and lower (and more predictable) long-term costs of operation. Download the B. Braun Medical white paper. The post High-volume manufacturing: Essential points to consider before you scale up appeared first […]